COMPANY PROFILE // THE 014 REPORT
Vaccinex, Inc.
VCNX (OTC)
Assembled from 1 government source in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberNo 10-K, 10-Q, 20-F or 40-F since 2025-04-15 (10-K, about 19 months): an active periodic filer has stopped filing.
- AmberNT 10-K filed on 2025-04-01: notice that a periodic report would be late.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-03-07 and 1 more time (last 24 months).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
VACCINEX, INC. is an SEC-registered operating company in pharmaceutical preparations, incorporated in DE, based in Rochester, NY; listed as VCNX (OTC).[source] It reported revenue of $601,000 for the fiscal year ended 2024-12-31.[source] It has filed 0 documents with the SEC in the last 12 months; the latest is Form 10-K, filed 2025-04-15.[source] Seraphix flags 3 items from these records: 8-K Item 3.01 filed; NT 10-K filed on 2025-04-01; No 10-K, 10-Q, 20-F or 40-F since 2025-04-15 (10-K, about 19 months).[source]
- red0
- amber3
- info0
- CLEAR25
- POSSIBLE MATCH1
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Legal counsel, as publicly named
- Hogan Lovells US LLP · Exhibit 5.1 legal opinion, S-3 filed 2024-10-16
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 25 CLEAR, 1 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001205922 | source |
| EIN | 16-1603202 | source |
| NY DOS ID | 2636560 | record |
| Business address (SEC) | 1895 MOUNT HOPE AVE, ROCHESTER, NY, 14620 | source |
Does not exist in the records we hold: LEI, UEI, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2025-04-15 filing Annual report (10-K) · SEC EDGAR
- 2025-04-01 filing NT 10-K · SEC EDGAR
- 2025-03-27 filing 15-12G · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing EFFECT · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
- 2025-03-25 filing POS AM · SEC EDGAR
170 earlier entries
- 2025-03-25 filing POS AM
- 2025-03-25 filing POS AM
- 2025-03-25 filing POS AM
- 2025-03-25 filing S-8 POS
- 2025-03-25 filing S-8 POS
- 2025-03-19 officer change 8-K items 5.02
- 2025-03-17 filing 25
- 2025-03-07 filing 8-K items 3.01,7.01,9.01
- 2024-12-17 filing 8-K items 3.01,8.01,9.01
- 2024-11-18 filing SC 13D/A
- 2024-11-14 filing 8-K items 1.01,3.02,9.01
- 2024-11-14 filing Quarterly report (10-Q)
- 2024-10-25 filing 424B3
- 2024-10-24 filing EFFECT
- 2024-10-22 filing CORRESP
- 2024-10-21 filing UPLOAD
- 2024-10-16 filing S-3
- 2024-10-09 filing 8-K items 3.01
- 2024-09-27 filing D
- 2024-09-20 filing SC 13D/A
- 2024-09-20 filing SC 13D/A
- 2024-09-19 filing 8-K items 1.01,3.02,9.01
- 2024-09-13 officer change 8-K items 5.02
- 2024-08-20 filing 8-K items 8.01
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-08-14 filing 8-K items 7.01,9.01
- 2024-08-07 filing SC 13D/A
- 2024-08-01 filing SC 13D/A
- 2024-07-31 filing 8-K items 8.01,9.01
- 2024-07-08 filing 424B3
- 2024-07-05 filing EFFECT
- 2024-07-02 filing CORRESP
- 2024-07-01 filing UPLOAD
- 2024-06-27 filing S-3
- 2024-06-06 filing 8-K items 7.01,9.01
- 2024-05-15 filing Quarterly report (10-Q)
- 2024-05-10 filing S-8
- 2024-05-09 filing 424B3
- 2024-05-09 filing 8-K items 5.07
- 2024-05-08 filing EFFECT
- 2024-05-08 filing S-3/A
- 2024-05-02 filing CORRESP
- 2024-05-02 filing UPLOAD
- 2024-04-26 filing S-3
- 2024-04-25 filing 10-K/A
- 2024-04-16 filing EFFECT
- 2024-04-16 filing 424B3
- 2024-04-12 filing CORRESP
- 2024-04-12 filing D
- 2024-04-12 filing D
- 2024-04-12 filing 8-K items 3.01
- 2024-04-12 filing D
- 2024-04-03 filing UPLOAD
- 2024-04-02 filing ARS
- 2024-04-02 filing Proxy statement
- 2024-04-02 filing S-3
- 2024-04-02 filing Annual report (10-K)
- 2024-04-02 filing NT 10-K
- 2024-04-01 filing 8-K items 1.01,3.02,5.03,9.01
- 2024-03-28 filing 8-K items 8.01,9.01
- 2024-03-28 filing 424B5
- 2024-03-27 filing 8-K items 8.01
- 2024-03-04 officer change 8-K items 5.02
- 2024-02-21 filing 8-K items 8.01,9.01
- 2024-02-15 filing 8-K items 3.03,5.03,8.01,9.01
- 2024-02-13 filing 8-K items 5.07
- 2024-02-13 filing SC 13D/A
- 2024-02-12 filing SC 13D/A
- 2024-02-08 filing 8-K/A items 9.01
- 2024-02-07 filing 8-K items 1.01,3.02,9.01
- 2024-01-19 filing EFFECT
- 2024-01-19 filing 424B3
- 2024-01-17 filing CORRESP
- 2024-01-16 filing UPLOAD
- 2024-01-10 filing S-3
- 2024-01-08 filing Proxy statement
- 2023-12-28 filing PRE 14A
- 2023-11-13 filing Quarterly report (10-Q)
- 2023-10-26 filing 8-K items 7.01,9.01
- 2023-10-18 filing SC 13D/A
- 2023-10-13 filing 8-K items 3.01,8.01
- 2023-10-12 filing SC 13D/A
- 2023-10-04 filing 8-K items 1.01,9.01
- 2023-10-02 filing 424B4
- 2023-09-28 filing EFFECT
- 2023-09-28 filing S-1MEF
- 2023-09-27 filing 8-K items 7.01
- 2023-09-26 filing SC 13D/A
- 2023-09-26 filing CORRESP
- 2023-09-26 filing CORRESP
- 2023-09-26 filing 8-K items 7.01,9.01
- 2023-09-26 filing S-1/A
- 2023-09-22 filing 8-K items 3.03,5.03,8.01,9.01
- 2023-09-22 filing 8-K items 1.01,3.02,9.01
- 2023-09-20 filing UPLOAD
- 2023-09-14 filing Registration (S-1)
- 2023-09-13 filing 8-K items 5.07
- 2023-08-22 filing 8-K items 1.01,3.02,9.01
- 2023-08-14 filing Proxy statement
- 2023-08-14 filing Quarterly report (10-Q)
- 2023-08-04 filing PRE 14A
- 2023-07-11 filing 424B3
- 2023-07-10 filing EFFECT
- 2023-07-07 filing CORRESP
- 2023-06-20 filing UPLOAD
- 2023-06-14 filing S-3
- 2023-05-30 filing 8-K items 3.01
- 2023-05-25 filing SC 13D/A
- 2023-05-19 filing 8-K items 8.01,9.01
- 2023-05-19 filing 424B5
- 2023-05-15 filing 8-K items 1.01,3.02,9.01
- 2023-05-15 filing Quarterly report (10-Q)
- 2023-05-12 filing 8-K items 5.07
- 2023-04-12 filing EFFECT
- 2023-04-10 filing CORRESP
- 2023-04-07 filing UPLOAD
- 2023-04-06 filing ARS
- 2023-04-06 filing Proxy statement
- 2023-04-05 filing SC 13D/A
- 2023-04-03 filing S-3
- 2023-04-03 filing 8-K items 1.01,3.02,9.01
- 2023-03-31 filing Annual report (10-K)
- 2023-03-23 officer change 8-K items 5.02
- 2023-03-09 filing 8-K items 7.01,9.01
- 2023-02-01 filing 424B3
- 2023-01-31 filing EFFECT
- 2023-01-27 filing CORRESP
- 2023-01-26 filing UPLOAD
- 2023-01-24 filing S-3
- 2022-11-29 filing SC 13D/A
- 2022-11-28 filing SC 13D/A
- 2022-11-25 filing 8-K items 1.01,3.02,9.01
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-11-10 filing 8-K items 7.01,9.01
- 2022-10-11 filing 8-K items 3.01
- 2022-09-13 filing 8-K items 7.01,9.01
- 2022-08-15 filing Quarterly report (10-Q)
- 2022-08-08 filing 8-K items 8.01,9.01
- 2022-08-01 filing 8-K items 7.01,9.01
- 2022-06-10 filing 8-K items 7.01,9.01
- 2022-05-17 filing 424B5
- 2022-05-16 filing Quarterly report (10-Q)
- 2022-05-13 filing 8-K items 5.07
- 2022-04-29 filing 424B3
- 2022-04-27 filing EFFECT
- 2022-04-25 filing CORRESP
- 2022-04-14 filing UPLOAD
- 2022-04-11 filing S-3
- 2022-04-05 filing Proxy statement
- 2022-04-04 officer change 8-K items 5.02
- 2022-03-31 filing Annual report (10-K)
- 2022-03-08 officer change 8-K items 5.02
- 2022-02-14 filing SC 13D/A
- 2022-02-10 filing SC 13D
- 2022-01-31 filing 8-K items 1.01,3.02,8.01,9.01
- 2022-01-26 filing 8-K items 8.01,9.01
- 2021-11-08 filing Quarterly report (10-Q)
- 2021-08-16 filing Quarterly report (10-Q)
- 2021-08-03 filing 8-K items 1.02
- 2021-05-17 officer change 8-K items 2.02,5.02,9.01
- 2021-05-17 filing Quarterly report (10-Q)
- 2021-05-12 filing 8-K items 5.07
- 2021-04-06 filing Proxy statement
- 2021-03-31 filing Annual report (10-K)
- 2021-03-25 officer change 8-K items 5.02
- 2021-03-16 filing 8-K items 2.02,9.01
- 2021-02-19 filing 8-K items 8.01,9.01
- 2020-12-09 officer change 8-K/A items 5.02
- 2020-11-20 filing 10-Q/A
- 2020-11-13 filing Quarterly report (10-Q)
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2025-04-15 (older) 10-K filed
- 2025-04-01 (older) NT 10-K filed
- 2025-03-27 (older) 15-12G filed
- 2025-03-25 (older) EFFECT filed
- 2025-03-25 (older) EFFECT filed
- 2025-03-25 (older) EFFECT filed
- 2025-03-25 (older) EFFECT filed
- 2025-03-25 (older) EFFECT filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- No listing symbol is held for this company.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
3 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1205922 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | VCNX / OTC | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 161603202 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001205922 | SEC EDGAR / IRS |
possible match: matched by name only, not merged (1)
Identifiers carried by records that share the company's exact name. Not merged into the identity above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| EPA FRS id | 110071517374 (VACCINEX INC) | name-exact:legal-name: same registered legal name as 'VACCINEX, INC.' | EPA ECHO facilities |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2024-12-31) | $601,000 | 2024-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 05:14 UTC | Report an error |
| Net income (loss) (fiscal year ended 2024-12-31) | -$18,634,000 | 2024-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 05:14 UTC | Report an error |
| Total assets (at 2024-12-31) | $2,596,000 | 2024-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 05:14 UTC | Report an error |
| Stockholders' equity (at 2024-12-31) | -$2,488,000 | 2024-12-31 | 10-K, XBRL StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | as filed | 2026-11-20 05:14 UTC | Report an error |
| Cash and cash equivalents (at 2024-12-31) | $1,107,000 | 2024-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 05:14 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2025-04-15 | SEC EDGAR company profile | as filed | 2026-11-20 05:14 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2025-04-15 | SEC EDGAR company profile | as filed | 2026-11-20 05:14 UTC | Report an error |
| State of incorporation | DE | 2025-04-15 | SEC EDGAR company profile | as filed | 2026-11-20 05:14 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2025-04-15 | SEC EDGAR company profile | as filed | 2026-11-20 05:14 UTC | Report an error |
| Business address | 1895 MOUNT HOPE AVE, ROCHESTER, NY, 14620 | 2025-04-15 | SEC EDGAR company profile | as filed | 2026-11-20 05:14 UTC | Report an error |
| Exchanges | OTC | 2025-04-15 | SEC EDGAR company profile | as filed | 2026-11-20 05:14 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2024-12-31) | -$16,186,000 | 2024-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 05:14 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31) | $22,000 | 2024-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 05:14 UTC | Report an error |
| Long-term debt (at 2024-12-31) | $0 | 2024-12-31 | 10-K, XBRL LongTermDebtNoncurrent | as filed | 2026-11-20 05:14 UTC | Report an error |
| Operating lease liabilities (at 2023-12-31) | $145,764 | 2023-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 05:14 UTC | Report an error |
| Form D total offering amount (D filed 2024-09-27) | $9,224,732 | 2024-09-27 | D | as filed | 2026-11-20 05:14 UTC | Report an error |
| Form D total amount sold (D filed 2024-09-27) | $200,155 | 2024-09-27 | D | as filed | 2026-11-20 05:14 UTC | Report an error |
| Form D industry group | Pharmaceuticals | 2024-09-27 | D | as filed | 2026-11-20 05:14 UTC | Report an error |
| Form D revenue range | $1 - $1,000,000 | 2024-09-27 | D | as filed | 2026-11-20 05:14 UTC | Report an error |
| Form D date of first sale | 2024-09-18 | 2024-09-27 | D | as filed | 2026-11-20 05:14 UTC | Report an error |
Latest report: 10-K for the period ended 2024-12-31, filed 2025-04-15 · accession 0000950170-25-054318
Old data: the newest 10-Q or 10-K in SEC company facts has no later XBRL values.
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $601,000 | 12 months ended 2024-12-31 | 10-K | 2025-04-15 | 0000950170-25-054318 | 2026-11-20 05:14 UTC | Report an error |
| Net income (loss) | -$18,634,000 | 12 months ended 2024-12-31 | 10-K | 2025-04-15 | 0000950170-25-054318 | 2026-11-20 05:14 UTC | Report an error |
| Interest expense | $2,000 | 12 months ended 2024-12-31 | 10-K | 2025-04-15 | 0000950170-25-054318 | 2026-11-20 05:14 UTC | Report an error |
| Cash and cash equivalents | $1,107,000 | at 2024-12-31 | 10-K | 2025-04-15 | 0000950170-25-054318 | 2026-11-20 05:14 UTC | Report an error |
| Contract liabilities, current | $0 | at 2024-12-31 | 10-K | 2025-04-15 | 0000950170-25-054318 | 2026-11-20 05:14 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2025-04-15 Filing 10-K filed
- 2025-04-01 Filing NT 10-K filed
- 2025-03-27 Filing 15-12G filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing EFFECT filed
- 2025-03-25 Filing POS AM filed
- 2025-03-25 Filing POS AM filed
- 2025-03-25 Filing POS AM filed
- 2025-03-25 Filing POS AM filed
- 2025-03-25 Filing POS AM filed
- 2025-03-25 Filing POS AM filed
- 2025-03-25 Filing POS AM filed
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
EPA ECHO facilities (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchVACCINEX INC · exact legal name · sx:epa:110071517374 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
2 state and city records carry this company's exact name, from 2 sources. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchVaccinex Inc. · exact legal name · sx:ctgov:hc4bf7863c1fde71c Compare
New York corporations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchVACCINEX, INC. · exact legal name · sx:nydos:2636560 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1205922.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001205922. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.